However, in a study of determining the key epigenetic genes in AML, Hu et al. found that the hypomethylated ZNRF2 gene promotes the expression level of the corresponding mRNA and can be used as a target for AML treatment [8]. Here, ZNRF2 is linked to acute myeloid leukemia.